This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Altria Group has been evolving with the changing industry dynamics. Given the rising health consciousness and stern government regulations to discourage smoking, this tobacco behemoth has been moving beyond traditional cigarettes and expanding in the smokeless category. We note that revenues from the oral product category have been steadily rising on the back of growing popularity for reduced risk products. In this respect, Altria is gaining from the sale of IQOS in United States, through its licensing deal with Phillip Morris. Further, Altria’s investment in Cronos Group highlights its focus on exploring the cannabis market.
Altria (MO) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Altria (MO) closed at $45.99 in the latest trading session, marking a +0.02% move from the prior day.
Is Invesco High Yield Equity Dividend Achievers ETF (PEY) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for PEY
Altria (MO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Altria (MO) closed the most recent trading day at $45.41, moving -0.24% from the previous trading session.
Altria (MO) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Altria (MO) closed at $45.87, marking a +0.04% move from the previous day.
The Zacks Analyst Blog Highlights Meta Platforms, Altria Group, Applied Materials, McCormick and Hewlett Packard Enterprise
by Zacks Equity Research
Meta Platforms, Altria Group, Applied Materials, McCormick and Hewlett Packard Enterprise are included in this Analyst Blog.
Top Research Reports for Meta Platforms, Altria Group & Applied Materials
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Meta Platforms, Inc. (META), Altria Group, Inc. (MO) and Applied Materials, Inc. (AMAT).
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Altria (MO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Altria (MO) closed the most recent trading day at $46.48, moving +0.52% from the previous trading session.
Altria (MO) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Altria (MO) closed at $46.44, marking a +0.13% move from the previous day.
Should Investors Buy Big Tobacco Stocks?
by Shaun Pruitt
With their total returns being impressively better than the broader market this year, investors might want to consider these equities for 2023 as well.
Altria (MO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Altria (MO) closed at $47.13 in the latest trading session, marking a +0.68% move from the prior day.
Altria (MO) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Altria (MO) closed at $46.86 in the latest trading session, marking a +1.06% move from the prior day.
Altria (MO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Altria (MO) closed at $47.63 in the latest trading session, marking a +1.32% move from the prior day.
Here's Why Lululemon (LULU) is Poised for Earnings Beat in Q3
by Zacks Equity Research
lululemon's (LULU) Q3 results are expected to benefit from continued business momentum, robust traffic trends in both stores and e-commerce, and SG&A leverage.
Brown-Forman (BF.B) to Retain Its Earnings Beat Streak in Q2
by Zacks Equity Research
Brown-Forman's (BF.B) Q2 results are expected to gain from strong demand for its brands, mainly the resurgence of Jack Daniel's Tennessee Whiskey, and growth across all geographic clusters.
Altria Group, Inc. (MO) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Zacks.com users have recently been watching Altria (MO) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Altria (MO) Looks Well-Poised on Pricing, Oral Tobacco Products
by Zacks Equity Research
Altria (MO) gains from its pricing power and focus on Oral Tobacco Products amid a rising cost scenario.
Should iShares Select Dividend ETF (DVY) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for DVY
Altria Group, Inc. (MO) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Altria (MO) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Is iShares Select Dividend ETF (DVY) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for DVY
Is Invesco High Yield Equity Dividend Achievers ETF (PEY) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for PEY
Altria Group, Inc. (MO) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Altria (MO) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Altria (MO) Q3 Earnings Lag Estimates, Revenues Decline Y/Y
by Zacks Equity Research
Altria's (MO) third-quarter 2022 results reflect an increase in earnings due to solid pricing. However, net revenues come in lower due to soft revenues from the smokeable product unit.
Altria (MO) Q3 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Altria (MO) delivered earnings and revenue surprises of -2.29% and 3.70%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Altria's (MO) Q3 Earnings Upcoming: Key Factors to Note
by Zacks Equity Research
Altria's (MO) third-quarter 2022 results are likely to reflect gains from pricing and strength in the oral tobacco products space, while cost inflation may have been a concern.